Author: Jesse Landry

In the world of cybersecurity, the big names get all the ink. Fortune 500 with threat intel war rooms and SOC teams that make Fort Knox look sloppy. But here’s the truth the industry doesn’t like to talk about: 95% of U.S. businesses don’t have a dedicated security pro. Not one. The SMB segment, the very backbone of the economy, is a $2 trillion open door, and most vendors don’t bother to knock. Zip Security didn’t ask for permission. They built the key. Founded in 2022 by Joshua Zweig and Gabriela Merz, two former Palantir engineers who got their start…

When generative AI video gets real enough for Hollywood to start writing checks and not cease-and-desist letters, that’s not just a market signal, it’s a movement. And Moonvalley just became its gravitational center. The Toronto-based AI research company locked in $84 million in fresh funding, bringing their total to $154 million. Led by General Catalyst, who clearly know a rocketship when they see one, the round also drew heavyweights like Creative Artists Agency (CAA), CoreWeave, Comcast Ventures, Khosla Ventures, and Y Combinator back into the mix. When VCs show up twice, you’re not a maybe, you’re a multiplier. Moonvalley was…

The network doesn’t lie, it remembers everything. Every circuit. Every VLAN. Every forgotten diagram taped to the side of a rack in a broom-closet datacenter that someone still swears is “production.” And in a world where AI workloads are stacking GPUs like poker chips and legacy systems are breaking under the weight of their own spreadsheets, one truth is clearer than ever: if your infrastructure doesn’t know itself, it can’t scale. NetBox Labs just dropped a $35 million Series B to make sure it does. Led by NGP Capital, with new firepower from Sorenson Capital and Headline, and returning conviction…

Let’s talk about a startup that just dropped a $4M seed round like it was a mic, and left the rest of health tech scrambling to catch the beat. Asepha, Toronto-born, clinically bred, and built for the AI age, isn’t here to pitch sci-fi futures. They’re automating the hard, overlooked, soul-crushing parts of pharmacy workflows right now. Not in five years. Not in a vague “we’re working on it” roadmap. Today. And they’ve got the data receipts to back it. It starts with Dr. Eunice Wu, a PharmD with six years deep in the trenches, Shoppers, BC Children’s, Vancouver General.…

Landscaping might not sound like a tech revolution, until you meet the team that just turned your backyard into a dataset and your design vision into a drag-and-drop experience. Duranta, the Seattle-based SaaS startup built by the engineering crew behind Aurora Solar, just closed a $7M seed round led by Base10 Partners. Pear VC, Coalition Operators, and Sunshine Lake Ventures joined the party, with angels like GitHub CEO Thomas Dohmke and PagerDuty co-founder Andrew Miklas putting their chips on the table. That’s not a cap table, it’s a résumé of people who’ve seen the movie and know how it ends.…

The construction industry has always worshipped at the altar of concrete timelines and steel budgets, until Dextall rolled in like a disruptor with a sawed-off. This isn’t just another prefab play dressed in tech-speak. This is a precision-guided collision between artificial intelligence, architecture, and affordability. And now, with $15 million in fresh Series A firepower, it’s about to scale like scaffolding in midtown. Let’s be clear: what Aurimas Sabulis and team are building isn’t prefab for the sake of prefab. It’s an intelligence layer that rewires the entire building envelope. Dextall Studio turns schematic design chaos into fabrication-ready precision in…

Imagine telling a room full of aerospace vets, pharma execs, and defense insiders that the future of drug manufacturing is 200 miles above their heads, inside a capsule blazing back to Earth at Mach 25. You’d get a few laughs, maybe a polite nod. But Varda Space Industries wasn’t pitching punchlines, they were building spacecraft. And this week, they locked in $187 million in Series C funding to prove that orbital manufacturing isn’t a sci-fi subplot. It’s a business model. One that’s working. Founded in November 2020 by Will Bruey, Delian Asparouhov, and Daniel Marshall, Varda has gone from cocktail-napkin…

There are two kinds of crypto stories out there. The ones where fortunes are made, and the ones where they vanish into the digital abyss because someone lost a key, a password, or a hard drive took an unplanned swim in the Atlantic. The $500 billion problem no one wanted to touch just met the one startup that was crazy enough, and smart enough, to solve it: Circuit. Harry Donnelly didn’t wake up one day and say, “I want to fix asset loss.” No, he was building a DeFi operating system for the big players, something clean, scalable, institutional-grade. But…

When a $10B investment drops in the pharma space, it’s not just capital, it’s a statement. And PCI Pharma Services just made theirs loud enough to echo across seven countries and 38 sites. Strategic dollars from Bain Capital and repeat conviction from Kohlberg don’t happen by accident. Neither does Mubadala doubling down or Partners Group keeping skin in the game. PCI Pharma Services isn’t new to the table. They’ve been packaging, formulating, scaling, and delivering since bell-bottoms were a thing the first time. But today’s PCI Pharma Services is a different beast. Under the leadership of CEO Salim Haffar, PCI…

Most biotech companies play at the cellular level. Pretzel Therapeutics? They’re untwisting mitochondrial dysfunction with the kind of precision that makes most molecular science look like finger painting. In a space where rare disease funding feels more like a prayer than a pitch, Pretzel just pulled in fresh backing from The Mito Fund, the venture arm of the United Mitochondrial Disease Foundation. And while the amount is hush-hush, the signal is loud: If you’re working on POLG disorders or mtDNA depletion syndromes and your lead compound is already in Phase 1, the right people take notice. Founded in 2019 by…